Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro
Cherney DZI, Dekkers CCJ, Barbour SJ, Cattran D, Abdul Gafor AH, Greasley PJ, et al
But how much pain people feel doesnt appear to be connected to how severe their gastroparesis is, or how slowly their stomach empties
Here's your fully formatted, SEO-optimized version of the article on Melanotan II , now using headers, enhanced content, and cited sources with inline links to improve authority and readability
Here are two of the most notable experiments to date: In an 11-day study, obese mice treated with 20mg/kg of 5-amino-1MQ trice daily experienced a 5.1% weight reduction from baseline, while control mice gained 1.4% in body weight